¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Ivy bleeding time test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • patch test
    ÇǺÎÁ¢Ã˰˻ç, øÆ÷°Ë»ç
  • paternity test
    Ä£ÀÚ°¨Á¤
  • penile tumescence test
    À½°æÆØÃ¢°Ë»ç
  • quantitative test
    Á¤·®°Ë»ç
  • radioallergosorbent test
    ¹æ»ç¾Ë·¹¸£±âÇ׿øÈíÂø°Ë»ç
  • radioimmunosorbent test
    ¹æ»ç¸é¿ªÈíÂø°Ë»ç
  • renal function test
    ÄáÆÏ±â´É°Ë»ç, ½ÅÀå±â´É°Ë»ç
  • righting reflex test
    Á÷¸³¹Ý»ç°Ë»ç, ¹Ù·Î¼­±â¹Ý»ç°Ë»ç
  • ring test
    °í¸®Ä§Àü°Ë»ç
  • Rorschach test
    ·Î¸£»þÈå°Ë»ç
  • Sabin-Feldman dye test
    ¼¼À̺ó-Æçµå¸Õ»ö¼Ò°Ë»ç
  • solubility test
    ¿ëÇØµµ°Ë»ç
  • specific gravity test
    ºñÁß°Ë»ç
  • spot test
    Á¡Àû°Ë»ç
  • stamp test
    ¿ìÇ¥ÆÄ¿­°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • finger-to-finger test
    ¼Õ°¡¶ô¸Â´ë±â°Ë»ç
  • fistula test
    »û±æ°Ë»ç, ´©°ø°Ë»ç
  • flocculation test
    ¼ØÅÐħÀü°Ë»ç
  • fluctuation test
    µé³¯Âߺ¯À̰˻ç
  • fluorescent antibody test
    Çü±¤Ç×ü°Ë»ç
  • fluorescent treponemal antibody test
    Çü±¤¸Åµ¶Ç×ü°Ë»ç
  • forced duction test
    °­Á¦´ç±è°Ë»ç
  • forward traction test
    ¾ÕÂÊ´ç±è°Ë»ç
  • four-prism-diopter test
    »çÇÁ¸®Áòµð¿ÉÅͰ˻ç
  • goodness of fit test
    ÀûÇÕµµ°ËÁ¤
  • gait test
    °ÉÀ½°Ë»ç, º¸Çà°Ë»ç
  • germ tube test
    ¹ß¾Æ°ü°Ë»ç
  • glaucoma provocative test
    ³ì³»ÀåÀ¯¹ß°Ë»ç
  • glucose insulin tolerance test
    Æ÷µµ´çÀν¶¸°°ßµõ°Ë»ç
  • glucose tolerance test
    Æ÷µµ´ç°ßµõ°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • VDRL flocculation test
    VDRL¸é»ó¹ÝÀÀ.
  • Voges-Proskauer test
    º¸°Ô½º ÇÁ·Î½ºÄ«¿ì¿¡¸£½ÃÇè, VP½ÃÇè
  • Wasserman test
    ¹Ù¼¼¸£¸¸ ¹ÝÀÀ
  • Watson-Schwartz test
    ¿ÍÆ®½¼-½¬¿Í¸£Ã÷ ½ÃÇè
  • Weber test
    ¿þ¹ö½ÃÇè
  • Weber test
    ¿þ¹ö°Ë»ç¹ý, ÆíÀ§°Ë»ç
  • Western blot test
    ¿þ½ºÅϺí·Ô½ÃÇè
  • Westgard quality control test
    ¿þ½ºÆ®°¡µåÁ¤µµ°ü¸®°Ë»ç¹ý
  • Widal test
    À§´Þ½ÃÇè.
  • Widal test
    À§´Þ½ÃÇè
  • Winn test
    À© Á¾¾ç¸é¿ªÁßÈ­½ÃÇè
  • Worth 4-dot test
    ¿öÆ®4µî°Ë»ç
  • Zondek-Aschheim test
    Á¸µ¦-¾Æ½¬ÇÏÀÓ ½ÃÇè
  • abrasion test
    ¸¶¸ê½ÃÇè(بØþãËúÐ).
  • absorption test
    Èí¼ö½ÃÇè
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • recovery time
    ȸº¹ ±â°£ (üáÜÖ Ñ¢Êà)
  • recovery time
    ȸº¹ ±â°£, ȸº¹ ½Ã°£
  • reflex time
    ¹Ý»ç½Ã°£(ÚãÞÒãÁÊà).
  • relaxation time
    À̿Ͻð£ (ì¬èÐãÁÊà)
  • relaxation time
    ÀÌ¿Ï ½Ã°£
  • relaxation time
    À̿Ͻð£(ì¬èÐãÁÊà).
  • repetition time (TR)
    ¹Ýº¹ ½Ã°£
  • retention time
    Á¤Ã¼½Ã°£
  • reverberation time
    ÀÜÇâ½Ã°£(íÑúÂãÁÊà).
  • ring down time
    ¿©¿î ½Ã°£ (æ®ê¤ ãÁÊà)
  • ring down time
    ¿©¿î ½Ã°£)
  • rise time
    »ó½Â ½Ã°£
  • rising time
    »ó½Â ½Ã°£
  • scan time
    ÁÖ»ç½Ã°£
  • sedimentation time
    ħ°­½Ã°£( ˽ãÁÊà).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
RTU real-time ultrasonography; relative time unit; renal transplantation unit
tcTOFA time constrained time-of-flight absorbance
TD the time required to double the number of cells in a given population; thermal death time
TE exhalation time; expiratory phase time
TI inversion time; temporal integration; terminal ileum; thalassemia intermedia; therapeutic index; tho...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
NT Nucleation time
OCTT Orocaecal transit time
PTT Partial Thromboplastine Time
aPTT Partial thromboplastin time
PST Per-stimulus-time
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dugas' test
    µÎ°¡½º ½ÃÇè
    °ß°üÀý Å»±¸¸¦ °ËÃâÇÏ´Â ½ÃÇèÀ¸·Î¼­, º´µç ÂÊÀÇ ¼ÕÀ» ¹Ý´ëÂÊÀÇ ¾î±ú¿¡ ³õ°í, ÆÈ²ÞÄ¡¸¦ °¡½¿ÀÇ Ãø¹æ¿¡ °¡Áö°í °£´Ù. À̰ÍÀ» ÇÒ ¼ö ¾øÀ¸¸é, °ß°üÀý Å»±¸°¡ ÀϾ °ÍÀÌ´Ù.
  • dye disappearance test
    »ö¼Ò À¯Ãâ °Ë»ç
  • D`Amato`s test
    ´Ù¸¶Åä ½ÃÇè
  • E. test
    ÀÌÀÌ±Û ½ÃÇè
    ¸Åµ¶ Ç÷ûÀÇ Ä§°­ ¹ÝÀÀ ½ÇÇèÀ¸·Î½á ÄÝ·¹½ºÅ׷Ѱú ½Ã½ºÅ×·ÑÀ» Æ÷È­ »óŰ¡ µÉ ¶§±îÁö ¿ì½É ¾ËÄڿüº Ç׿ø¿¡ °¡ÇÑ °Í.
  • Eberson's test
    À̹ö½¼ ½ÃÇè
    ÀӽйÝÀÀÀÇ Çϳª·Î, Aschheim-Zondek¹ýÀÇ º¯¹ý.
  • EDTA tolerance test
    EDTA ³»¼º °Ë»ç
    Á¤¸Æ Åõ¿©ÇÏ¿© ºÎ°©»ó¼± È£¸£¸óÀÇ ºÐºñ¸¦ ÃËÁø½ÃŰ´Â °ÍÀÌ ¸ñÀûÀÌ´Ù.
  • elastic test
    ź¼º ½ÃÇè
  • Elberg's test
    ¿¤½º¹ö±× ½ÃÇè
    ³ú Á¾¾çÀÇ Á¸À縦 ÆÇÁ¤Çϱâ À§ÇØ Èİ¢À» °Ë»çÇÏ´Â ¹æ¹ý.
  • electric pulp test
    Àü±â Ä¡¼ö °Ë»ç, Ä¡¼ö Àü±â °Ë»ç
  • Eleks gel-precipitin test
    ¿¤·ºÅ© ÇÑõ ÆòÆÇ ħ°­¹ý
    µðÇÁÅ׸®¾Æ µ¶¼Ò µ¿Á¤¹ý.
  • emergency test
    ÀÀ±Þ °Ë»ç
  • emulsification test
    ¿¡¸ÖÁ¯ ½ÃÇè
  • erythrocyte protoporphyrin test
    ÀûÇ÷±¸ ÇÁ·ÎÅäÆ÷¸£ÇǸ° ½ÃÇè
  • erythrocyte sedimentation test
    ÀûÇ÷±¸ ħ°­ ½ÃÇè
  • esculin hydrolysis test
    ¿¡½ºÄ𸰠°¡¼öºÐÇØ ½ÃÇè
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
PCR test <investigation> A very sensitive test that measures the presence or amount of RNA or DNA of a specific organism or virus (for example: HIV or CMV) in the blood or tissue. PCR tests such as HoffmannLa Roche's HIV RT PCR are being used to gauge HIV disease progression and the effect of particular treatments on HIV infection.
(09 Oct 1997)
vitamin B12 absorption test <investigation> This test measures the amount of vitamin B12 in the urine after ingesting a dose of B12. This test evaluates vitamin B12 absorption. The cells in the stomach produce a substance known as intrinsic factor. This substance combines with B12 to allow absorption in the distal ileum. The patient is given a small dose of radioactive B12 which can then be detected in the patients urine. Pernicious anaemia is the clinical result of B12 deficiency. Conditions that can result in an abnormal Schilling test include: deficiency of intrinsic factor, malabsorption or the development of an antibody to intrinsic factor. The Schilling test can be performed with or without administration of intrinsic factor to determine what the underlying cause for pernicious anaemia. Laxative use, renal insufficiency and hypothyroidism can all interfere with the results of this test.
(27 Sep 1997)
vitamin C test A tourniquet test used to determine presence of vitamin C deficiency or thrombocytopenia; a circle 2.5 cm in diameter, the upper edge of which is 4 cm below the crease of the elbow, is drawn on the inner aspect of the forearm, pressure midway between the systolic and diastolic blood pressure is applied above the elbow for 15 minutes, and a count of petechiae within the circle is made: 10, normal; 10 to 20, marginal zone; over 20, abnormal.
See: Rumpel-Leede test.
Synonym: capillary resistance test, vitamin C test.
(05 Mar 2000)
glucose oxidase paper strip test <chemical pathology> A qualitative test for glucose in the urine, in which glucose is oxidised to gluconic acid by glucose oxidase; a specific test, unless ascorbic acid is present.
(05 Mar 2000)
glucose tolerance test <chemical pathology, investigation> A special test where the blood glucose is measure in intervals after a glucose-rich meal is taken, a test used for diagnosing diabetes.
(27 Sep 1997)
VMA test A test for catecholamine-secreting tumours (pheochromocytoma and neuroblastoma) performed on a 24-hr urine specimen; it is based on the fact that vanillylmandelic acid is the major urinary metabolite of norepinephrine and epinephrine.
Synonym: 3-methoxy-4-hydroxymandelic acid test, VMA test.
(05 Mar 2000)
Volhard's test A test for renal function: the patient drinks 1500 ml of water on an empty stomach; if the patient was not dehydrated beforehand and the kidneys are normal, this fluid will be excreted by the end of 4 hr, with specific gravity of the urine being from 1.001 to 1.004.
(05 Mar 2000)
Vollmer test A tuberculin patch test.
(05 Mar 2000)
resorcinol test A test for fructosuria; fresh urine treated with resorcinol in acid gives a red precipitate in the presence of fructose; the precipitate should form a red solution in ethanol.
Synonym: Selivanoff's test.
(05 Mar 2000)
Meinicke test The first successful application (1917-1918) of immune precipitation to diagnosis of syphilis, now obsolete.
(05 Mar 2000)
glycosylated haemoglobin test <investigation> A blood test that measures a person's average blood glucose (sugar) level for the 2- to 3-month period before the test. See: haemoglobin A1C.
(09 Oct 1997)
Gmelin's test A test for bile in the urine or other body fluid; nitric acid, with a little nitrous acid, is cautiously added to a few milliliters of the material to be tested; if bile (bilirubin) is present, it is oxidised to varying degrees, thereby resulting in disklike zones that are (from the interface outward) yellow, red, violet, blue, and green; development of green and violet layers is essential to the validity of the test.
Synonym: Rosenbach-Gmelin test.
(05 Mar 2000)
pentagastrin test An alternative to histamine for stimulation of acid secretion in gastric analysis.
(05 Mar 2000)
Gofman test A test for various serum lipoproteins that contain cholesterol, as an index of the tendency to the development of atheromatous lesions and arteriosclerosis; the test is based on the differential flotation of molecules of various sizes when the serum is treated in an ultracentrifuge.
(05 Mar 2000)
Meltzer-Lyon test A test used in diagnosis of gallbladder conditions: 25 ml of a 25% solution of magnesium sulfate are delivered into the region of the sphincter of Oddi through a duodenal tube, causing contraction of the gallbladder, relaxation of the sphincter, and the expulsion of bile from the common duct and gallbladder; bile from the common duct is relatively pale and is expelled first, that from the gallbladder follows; samples aspirated from the tube are examined for pus cells, pigment granules, epithelial cells, cholesterol, etc.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á